On 10 November 2025, international pharmaceutical group Hikma inaugurated its third plant in Sidi Thabet, Ariana, with a $15 million investment. Covering 6,500 m², the facility will produce cardiovascular drugs, antibiotics, and diabetes treatments, strengthening Tunisia’s pharmaceutical sovereignty and exporting 30% to Francophone Africa. The project creates 40 additional jobs, emphasizing local expertise and continuous training.
